Immix Biopharma (IMMX) Interest Coverage Ratio (2021 - 2022)

Immix Biopharma has reported Interest Coverage Ratio for 6 years, with the latest figure at 30.29 in Q1 2026.

• Quarterly Interest Coverage Ratio fell 182.38% year-over-year to 30.29 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 101.15 (down 102.86% YoY) and the FY2025 annual result came in at 1.18, up 17.65% from the prior year.
• Interest Coverage Ratio retreated to 30.29 in Q1 2026 per IMMX's latest filing, from 28.84 in the prior quarter.
• Over five years, Interest Coverage Ratio peaked at 417.03 in Q4 2022 and troughed at 8259.02 in Q2 2022.
• A 5-year average of 875.41 and a median of 10.7 in 2024 frame the typical range for Interest Coverage Ratio.
• The widest YoY moves for Interest Coverage Ratio: up 161.68% in 2022, down 182850.63% in 2022.
• Over 5 years, Interest Coverage Ratio stood at 417.03 in 2022, then tumbled by 100.17% to 0.7 in 2023, then soared by 55.09% to 0.32 in 2024, then tumbled by 9017.25% to 28.84 in 2025, then decreased by 5.02% to 30.29 in 2026.
• According to Business Quant data, Interest Coverage Ratio over the past three periods registered 30.29, 28.84, and 5.09 for Q1 2026, Q4 2025, and Q3 2025 respectively.